| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.5M | +45.7% |
| SG&A Expense | $199K | +445.1% |
| Operating Income | -$2.6M | -46.5% |
| Interest Expense | $918K | — |
| Pre-tax Income | -$3.0M | -162.9% |
| Net Income | -$3.0M | -162.9% |
| EPS (Basic) | -$0.29 | -141.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.4M | +1567.6% |
| Current Assets | $8.6M | +1583.3% |
| Total Assets | $8.7M | +1228.0% |
| Current Liabilities | $976K | -56.0% |
| Long-term Debt | $91K | +0.0% |
| Total Liabilities | $976K | -57.2% |
| Stockholders' Equity | $7.7M | +571.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | -802.5% |
| Financing Cash Flow | $10.6M | +1444.2% |